Dimeric prion protein ligand activates Adgrg6 but does not rescue myelinopathy of PrP-deficient mice
Authors:
- Anna HenziAHAnna Henzi
- Assunta SenatoreASAssunta Senatore
- Asvin Kk LakkarajuALAsvin Kk Lakkaraju
- Claudia ScheckelCSClaudia Scheckel
- Jonas MühleJMJonas Mühle
- Regina ReimannRRRegina Reimann
- Silvia SorceSSSilvia Sorce
- Gebhard F.X. SchertlerGSGebhard F.X. Schertler
- Klaus V. ToykaKTKlaus V. Toyka
- Adriano AguzziAAAdriano Aguzzi
Preprint
Abstract
The adhesion G-protein coupled receptor Adgrg6 (formerly Gpr126) is instrumental in the development, maintenance and repair of peripheral nervous system myelin. The prion protein (PrP) is a potent activator of Adgrg6 and could be used as a potential therapeutic agent in treating peripheral demyelinating and dysmyelinating diseases. We designed a dimeric Fc-fusion protein comprising the myelinotrophic domain of PrP (FT 2 Fc), which activated Adgrg6 in vitro and exhibited favorable pharmacokinetic properties for in vivo treatment of peripheral neuropathies. While chronic FT 2 Fc treatment elicited specific transcriptomic changes in the sciatic nerves of PrP knockout mice, no amelioration of the peripheral demyelinating neuropathy was detected. Instead, RNA sequencing of sciatic nerves revealed downregulation of cytoskeletal and sarcomere genes, akin to the gene expression changes seen in myopathic skeletal muscle of PrP overexpressing mice. These results call for caution when devising myelinotrophic therapies based on PrP-derived Adgrg6 ligands. While our treatment approach was not successful, Adgrg6 remains an attractive therapeutic target to be addressed in other disease models or by using different biologically active Adgrg6 ligands. Summary blurb: A dimeric prion protein ligand activates Adgrg6 but fails to induce pro-myelination signaling upon chronic treatment in a mouse model of peripheral demyelination.Keywords
All Related Versions
- Published version: PLOS ONE, 15 (11), e0242137.
This publication has 51 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Fc‐fusion proteins: new developments and future perspectivesEMBO Molecular Medicine, 2012
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and EfficacyThe AAPS Journal, 2012
- Stabilisation of the Fc Fragment of Human IgG1 by Engineered Intradomain Disulfide BondsPLOS ONE, 2012
- Gpr126 is essential for peripheral nerve development and myelination in mammalsDevelopment, 2011
- Schwann Cell Dedifferentiation Is Independent of Mitogenic Signaling and Uncoupled to ProliferationJournal of Biological Chemistry, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- A G Protein–Coupled Receptor Is Essential for Schwann Cells to Initiate MyelinationScience, 2009
- Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic miceProceedings of the National Academy of Sciences, 2007
- Soluble Dimeric Prion Protein Binds PrPSc In Vivo and Antagonizes Prion DiseaseCell, 2003